2010 Guidelines Part 7: CPR Techniques and Devices: Writing Group Disclosures

Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/Honoraria Ownership Interest Consultant/Advisory Board Other
Diana M. Cave Legacy Health System, Emanuel Hospital, Emergency Services–RN, MSN; Portland Com. College–Institute for Health Prof.-Faculty/Instructor None None None None None None
Raul Gazmuri North Chicago VA Medical Center–Section Chief, Critical Care and Professor of Medicine Volume-Controlled Manual Ventilation during Resuscitation from Cardiac Arrest. Funded by Dessinier Corporation. Funds come
to my institution (Rosalind Franklin UniversityRFU) Vitamin-C Preserves Myocardial Distensibility during Resuscitation from
CA. Funded by Maribor University, Slovenia. Funds come to my institution (RFU)
None None Patent titled “Facilitation of Resuscitation from Cardiac Arrest by Erythropoietin” (pending) None None
Charles W. Otto University of Arizona–Professor None None None None None None
Vinay M. Nadkarni University of Pennsylvania/The Children’s Hospital of Philadelphia–Attending Physician, Departement of Anesthesia, Critical
Care and Pediatrics
None None None None None *Voluntary (Unpaid) member of Data Safety Monitoring Committee for Automated CPR device trial
Adam Cheng British Columbia Children’s Hospital: University Affiliated–Director, Pediatric Simulation Program American Heart Association RFP – educational grant. Money comes to my institution, and is distributed to our group of collaborative
pediatric hospitals
None None None None None
Steven C. Brooks University of Toronto–Clinician-Scientist PI-1. Univ.of Toronto Faculty of Medicine New Staff Grant. 01/07/2009–01/07/2010 A pilot study to explore missed opportunities
for public access defibrillation in OHCA and to determine the potential impact of emergency medical dispatchers. Role: PI
$10 000 unrestricted grant administered through the research institute 2. University of Toronto Connaught New Staff Matching
Grant 2009–2010. 04/05/2009–03/05/2011 Development of Centres of Excellence to Improve Outcomes after OHCAt: A Pilot Study.
Role: PI $23 700 unrestricted grant administered through the research institute 3. Ontario Ministry of Health and Long Term
Care and the Sunnybrook Medical Services Alternative Funding Plan Association. 04/22/2009–04/21/2010 2008–2009 Alternative
Funding Plan Phase III Innovation Fund Project Funding. Project: “Inventing the Future of Post Cardiac Arrest Care: Collaborative
Development of Standardized Patient Care Pathways at Sunnybrook Health Sciences Centre.” Role: PI $100 000 unrestricted grant
administered through the research institute Co-Investigator 1. National Institutes of Health Slutsky AS (PI) 01/09/2004–01/09/2009
From Bench to Bedside to Curbside. Clinical Research Consortium to improve Resuscitation. Role: Co-Investigator $2 454 201
US 2. Canadian Institute of Health Research Slutsky AS (PI) 01/04/2005–01/10/2010 Epistry component of the Resuscitation Outcomes
Consortium. Role: Co-Investigator $500 001 3. Laerdal Foundation for Acute Medicine Morrison LJ (PI) 01/12/2007–01/12/2010
Centre Grant Program for knowledge translation projects in post resuscitation care. Role: Co-Investigator $150 000 4. Heart
and Stroke Foundation of Canada. Morrison LJ & Dorian P (Co-PI’s) 01/12/2007–01/12/2009 Operating Grant in the Area of Resuscitation
and Knowledge Transfer for the Strategies in Post-Arrest Care (SPARC) project. Role: Co-Investigator $200 000
None None None None None
Mohamud Daya Oregon Health & Science University: Attending Physician–Associate Professor of Emergency Medicine PI Resuscitation Outcomes Consoritum – Portland Site, NHLBI, grant is awarded directly to the insitution (OHSU) None *Lectures at local, regional and national meetings, income is directly to me, last lectures CPR update at the Timberline EMS
conference, there was no honorarium but conference paid for my lodging Stroke Update in Corvallis at Samaritan Health, Honorarium
fee was 500 dollars Advanced 12 lead ECG diagnostic algoritms, Lecutre for Philips Healthcare at EMS today, honoarium for
2 lectures was 1000 dollars
*Stock held in the following health care companies; Johnson and Johnson – 250 shares Amgen – 100 shares Roche – 100 shares *Philips Health Care – Consultant on 12 lead ECG diagnostic algorithms and resuscitation products, no reimbursement for this
I am an EMS medical director for 2 fire departments and one 911 agency, this is a private contract and the money comes directly
to me, this is independent of my employment at OHSU which is at an 80% FTE level, my EMS activities are 20% FTE
Robert M. Sutton The Children’s Hospital of Philadelphia–Critical Care Attending *Unrestricted Research Grant Support through a Center of Excellence Grant from the Laerdal Found None None None None
Richard Branson University of Cincinnati-Associate Professor None SeQual. Sponsor of laboratory study of the use of oxygen concentrators in conjunction with mechanical ventilators for military
and mass casualty scenarios. $40 000. All monies are paid to the Univ. I have no financial interest in the company and do
not receive any personal income
Cardinal – makers of ICU and home care ventialtors. I am paid directly for speaking. Newport Medical makers of ICU and home
care ventilators. I am paid directly for speaking. *IKARIA – manufactures and distributes inhaled nitric oxide. I am paid directly
None *Bayer Pharmaceuticals. Treatment of ventilator associated pneumonia *KIngs Daughters Hospital Ashalnd KY. Paid directly to me
Mary Fran Hazinski Vanderbilt University School of Nursing—Professor; American Heart Association– Senior Science Editor Significant AHA compensation for my editing responsibilities- writing and editing of the 2010 AHA Guidelines for CPR and ECC None None None None None None
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts
    of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and
    submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period,
    or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity,
    or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less
    than “significant” under the preceding definition.

  • * Modest.

  • Significant.